Overview
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company's transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. Its portfolio contains well-known oncology drugs including Rituxan (non-Hodgkin's lymphoma), Avastin (colorectal
...
Read More and lung cancers), Herceptin (breast cancer), Tarceva (lung cancer), and Zelboraf (inoperable melanoma). Other drugs treat conditions such as age-related macular degeneration, cystic fibrosis, and asthma. Swiss pharmaceutical giant Roche owns Genentech.
Read Less
Read More and lung cancers), Herceptin (breast cancer), Tarceva (lung cancer), and Zelboraf (inoperable melanoma). Other drugs treat conditions such as age-related macular degeneration, cystic fibrosis, and asthma. Swiss pharmaceutical giant Roche owns Genentech.
Read Less
Ashley Magargee
See more contacts
Scientific Research and Development Services
,
Pharmaceutical and Medicine Manufacturing
,
Professional, Scientific, and Technical Services
,
Medical research
,
Adrenal pharmaceutical preparations
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
Contacts
Get in Touch with 3 Principals* and 8,678 Contacts
-
Ashley MagargeeChief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.